Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
440 | 26600 | 36.5 | 65% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
440 | 3 | NOCICEPTIN//OPIOID RECEPTORS//MORPHINE | 26600 |
121 | 2 | OPIOID RECEPTORS//MORPHINE//DELTA OPIOID RECEPTOR | 24293 |
3497 | 2 | NOCICEPTIN//ORPHANIN FQ//NOCICEPTIN ORPHANIN FQ | 1442 |
3876 | 2 | NEUROTROPIN//BUDIPINE//HYPERVENTILATION INDUCED NYSTAGMUS | 865 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NOCICEPTIN | authKW | 512527 | 2% | 91% | 473 |
2 | OPIOID RECEPTORS | authKW | 436934 | 3% | 44% | 844 |
3 | MORPHINE | authKW | 354213 | 6% | 21% | 1467 |
4 | DELTA OPIOID RECEPTOR | authKW | 286206 | 1% | 66% | 368 |
5 | ORPHANIN FQ | authKW | 277548 | 1% | 96% | 243 |
6 | OPIOIDS | authKW | 275229 | 5% | 17% | 1341 |
7 | BUDIPINE | authKW | 259364 | 2% | 57% | 13 |
8 | NOCICEPTIN ORPHANIN FQ | authKW | 254558 | 1% | 94% | 229 |
9 | MU OPIOID RECEPTOR | authKW | 247093 | 2% | 40% | 521 |
10 | NALOXONE | authKW | 184370 | 2% | 26% | 597 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 85640 | 35% | 1% | 8910 |
2 | Neurosciences | 72875 | 32% | 1% | 8246 |
3 | Endocrinology & Metabolism | 22957 | 13% | 1% | 3222 |
4 | Behavioral Sciences | 10445 | 5% | 1% | 1279 |
5 | Medicine, Research & Experimental | 7957 | 8% | 0% | 1970 |
6 | Chemistry, Medicinal | 4204 | 5% | 0% | 1168 |
7 | Anesthesiology | 3602 | 3% | 1% | 663 |
8 | Biochemistry & Molecular Biology | 3508 | 14% | 0% | 3650 |
9 | Psychology, Biological | 2366 | 1% | 1% | 313 |
10 | Physiology | 2116 | 4% | 0% | 1067 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | NEUROCODE AG | 110307 | 1% | 63% | 5 |
2 | CHEM BIOL PEPTIDE | 99278 | 0% | 81% | 104 |
3 | BIOACT SCI | 50147 | 1% | 16% | 9 |
4 | MED FOR ENTWICKLUNG | 47065 | 0% | 67% | 2 |
5 | AUSTRALIA HLTH PROMOT | 35300 | 0% | 100% | 1 |
6 | BEHAV BIOCHEM PROGRAM | 35300 | 0% | 100% | 1 |
7 | BIOACT SCI BIOCHEM | 35300 | 0% | 100% | 1 |
8 | CHEM WORKS GEDEON | 35300 | 0% | 100% | 1 |
9 | COLORADO SPRINGS ROCKY MT SLEEP | 35300 | 0% | 100% | 1 |
10 | FUNDED INTEGRATED UNDERSTANDING SLEEP C | 35300 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LIFE SCIENCES | 76481 | 4% | 6% | 1151 |
2 | NEUROPEPTIDES | 74525 | 2% | 16% | 401 |
3 | PEPTIDES | 52339 | 2% | 7% | 627 |
4 | EUROPEAN JOURNAL OF PHARMACOLOGY | 48976 | 4% | 4% | 1093 |
5 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 47842 | 4% | 4% | 934 |
6 | PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR | 37937 | 2% | 5% | 638 |
7 | BRAIN RESEARCH | 36168 | 5% | 3% | 1229 |
8 | REGULATORY PEPTIDES | 17722 | 1% | 6% | 269 |
9 | INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH | 17660 | 1% | 8% | 195 |
10 | NEUROENDOCRINOLOGY | 14738 | 1% | 5% | 241 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NOCICEPTIN | 512527 | 2% | 91% | 473 | Search NOCICEPTIN | Search NOCICEPTIN |
2 | OPIOID RECEPTORS | 436934 | 3% | 44% | 844 | Search OPIOID+RECEPTORS | Search OPIOID+RECEPTORS |
3 | MORPHINE | 354213 | 6% | 21% | 1467 | Search MORPHINE | Search MORPHINE |
4 | DELTA OPIOID RECEPTOR | 286206 | 1% | 66% | 368 | Search DELTA+OPIOID+RECEPTOR | Search DELTA+OPIOID+RECEPTOR |
5 | ORPHANIN FQ | 277548 | 1% | 96% | 243 | Search ORPHANIN+FQ | Search ORPHANIN+FQ |
6 | OPIOIDS | 275229 | 5% | 17% | 1341 | Search OPIOIDS | Search OPIOIDS |
7 | BUDIPINE | 259364 | 2% | 57% | 13 | Search BUDIPINE | Search BUDIPINE |
8 | NOCICEPTIN ORPHANIN FQ | 254558 | 1% | 94% | 229 | Search NOCICEPTIN+ORPHANIN+FQ | Search NOCICEPTIN+ORPHANIN+FQ |
9 | MU OPIOID RECEPTOR | 247093 | 2% | 40% | 521 | Search MU+OPIOID+RECEPTOR | Search MU+OPIOID+RECEPTOR |
10 | NALOXONE | 184370 | 2% | 26% | 597 | Search NALOXONE | Search NALOXONE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TOLL, L , BRUCHAS, MR , CALO', G , COX, BM , ZAVERI, NT , (2016) NOCICEPTIN/ORPHANIN FQ RECEPTOR STRUCTURE, SIGNALING, LIGANDS, FUNCTIONS, AND INTERACTIONS WITH OPIOID SYSTEMS.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 2. P. 419 -457 | 296 | 84% | 8 |
2 | BODNAR, RJ , (2004) ENDOGENOUS OPIOIDS AND FEEDING BEHAVIOR: A 30-YEAR HISTORICAL PERSPECTIVE.PEPTIDES. VOL. 25. ISSUE 4. P. 697 -725 | 388 | 80% | 100 |
3 | PASTERNAK, GW , PAN, YX , (2013) MU OPIOIDS AND THEIR RECEPTORS: EVOLUTION OF A CONCEPT.PHARMACOLOGICAL REVIEWS. VOL. 65. ISSUE 4. P. 1257 -1317 | 325 | 63% | 66 |
4 | MOGIL, JS , PASTERNAK, GW , (2001) THE MOLECULAR AND BEHAVIORAL PHARMACOLOGY OF THE ORPHANIN FQ/NOCICEPTIN PEPTIDE AND RECEPTOR FAMILY.PHARMACOLOGICAL REVIEWS. VOL. 53. ISSUE 3. P. 381 -415 | 268 | 84% | 314 |
5 | SCHRODER, W , LAMBERT, DG , KO, MC , KOCH, T , (2014) FUNCTIONAL PLASTICITY OF THE N/OFQ-NOP RECEPTOR SYSTEM DETERMINES ANALGESIC PROPERTIES OF NOP RECEPTOR AGONISTS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 16. P. 3777 -3800 | 214 | 85% | 25 |
6 | GENDRON, L , CAHILL, CM , VON ZASTROW, M , SCHILLER, PW , PINEYRO, G , (2016) MOLECULAR PHARMACOLOGY OF DELTA-OPIOID RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 3. P. 631 -700 | 391 | 53% | 0 |
7 | LAMBERT, DG , (2008) THE NOCICEPTIN/ORPHANIN FQ RECEPTOR: A TARGET WITH BROAD THERAPEUTIC POTENTIAL.NATURE REVIEWS DRUG DISCOVERY. VOL. 7. ISSUE 8. P. 694 -U11 | 191 | 90% | 168 |
8 | CHIOU, LC , LIAO, YY , FAN, PC , KUO, PH , WANG, CH , RIEMER, C , PRINSSEN, EP , (2007) NOCICEPTIN/ORPHANIN FQ PEPTIDE RECEPTORS: PHARMACOLOGY AND CLINICAL IMPLICATIONS.CURRENT DRUG TARGETS. VOL. 8. ISSUE 1. P. 117 -135 | 207 | 95% | 90 |
9 | DHAWAN, BN , CESSELIN, F , RAGHUBIR, R , REISINE, T , BRADLEY, PB , PORTOGHESE, PS , HAMON, M , (1996) INTERNATIONAL UNION OF PHARMACOLOGY .12. CLASSIFICATION OF OPIOID RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 48. ISSUE 4. P. 567-592 | 240 | 84% | 461 |
10 | WALDHOER, M , BARTLETT, SE , WHISTLER, JL , (2004) OPIOID RECEPTORS.ANNUAL REVIEW OF BIOCHEMISTRY. VOL. 73. ISSUE . P. 953-990 | 215 | 76% | 361 |
Classes with closest relation at Level 3 |